In vivo characterization of the angiotensin-(1-7)-induced dopamine and γ-aminobutyric acid release in the striatum of the rat

European Journal of Neuroscience

Volumn 22, Issue 3, 2005, Pages 658-664

  Stragier, Bart ^a   Hristova, Ilina ^a   Sarre, Sophie ^a   Ebinger, Guy ^a   Michotte, Yvette ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Aminopeptidase A; Angiotensin (3 7); D alanine angiotensin (1 7); Insulin regulated aminopeptidase; Nitric oxide

Indexed keywords

4 AMINOBUTYRIC ACID; A 779; AMINOPEPTIDASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; DOPAMINE; EC 33; GLUTAMYL AMINOPEPTIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; CHROMATOGRAPHY; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; GAMMA-AMINOBUTYRIC ACID; IMIDAZOLES; MALE; MICRODIALYSIS; NG-NITROARGININE METHYL ESTER; PEPTIDE FRAGMENTS; PYRIDINES; RATS; RATS, WISTAR; SULFONIC ACIDS; TETRAZOLES; TIME FACTORS;

EID: 23944468012     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04188.x     Document Type: Article

References (41)

1. 4) receptor is the enzyme insulin-regulated aminopeptidase. J. Biol. Chem., 276, 48623-48626.
2. Barnett, J., Chow, J., Ives, D., Chiou, M., Mackenzie, R., Osen, E., Nguyen, B., Tsing, S., Bach, C. & Freire, J. (1994) Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim. Biophys. Acta., 1209, 130-139.
3. Braszko, J.J., Kulakowska, A. & Wisniewski, K. (1995) Angiotensin II and its 3-7 fragment improve recognition but not spatial memory in rats. Brain Res. Bull., 37, 627-631.
4. Brosnihan, K.B., Li, P., Tallant, E.A. & Ferrario, C.M. (1998) Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biol. Res., 31, 227-234.
5. Chansel, D. & Ardaillou, R. (1998) Active metabolites derived from angiotensin II. Nephrology, 19, 427-432.
6. Ferrario, C.M., Chappell, M.C., Tallant, E.A., Brosnihan, K.B. & Diz, D.I. (1997) Counterregulatory actions of angiotensin-(1-7). Hypertension, 20, 535-541.
7. Ferrario, C.M. & Iyer, S.N. (1998) Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system. Regul. Pept., 30, 13-18.
8. 3H]candesartan to intact cells and membrane preparations. Biochem. Pharmacol., 63, 1273-1279.
9. Freeman, E.J., Chisolm, G.M., Ferrario, C.M. & Tallant, E.A. (1996) Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension, 28, 104-108.
10. Furfine, E.S., Harmon, M.F., Paith, J.E. & Garvey, E.P. (1993) Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry, 32, 8512-8517.
11. Guevara-Guzman, R., Emson, P.C. & Kendrick, K.M. (1994) Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem., 62, 807-810.
12. Handa, R.K. (1999) Angiotensin-(1-7) can interact with the rat proximal tubule AT (4) receptor system. Am. J. Physiol., 111, F75-F83.
13. Handa, R.K. (2000) Metabolism alters the selectivity of angiotensin-(1-7) receptor ligands for angiotensin receptors. J. Am. Nephrol., 11, 1677-1386.
14. Handa, R.K. (2001) Autoradiographic analysis and regulation of angiotensin receptor subtypes AT (4), AT (1) and AT (1-7) in the kidney. Am. J. Physiol. Renal Physiol., 281, 936-947.
15. Handa, R.K., Ferrario, C.M. & Strandhoy, J.W. (1996) Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am. J. Physiol., 270, F141-F147.
16. Herbst, J.J., Ross, S.A., Scott, H.M., Bobin, S.A., Morris, N.J., Lienhard, G.E. & Keller, S.R. (1997) Insulin stimulates cell surface aminopeptidase activity towards vasopressin in adipocytes. Am. J. Physiol., 272, E600-E606.
17. Iyer, S.N., Yamada, K., Diz, D.I., Ferrario, C.M. & Chappell, M.C. (2000) Evidence that prostaglandines mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. J. Cardiovasc. Pharmacol., 36, 109-117.
18. Jaiswal, N., Tallant, E.A., Jaiswal, R.K., Diz, D.I. & Ferrario, C.M. (1993) Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. J. Pharmacol. Exp. Ther., 265, 664-673.
19. 4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin-7, on spatial learning in rats. Neuroscience, 124, 341-349.
20. 4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). J. Neurochem., 86, 344-350.
21. Lynch, K.R., Simnad, V.I., Ben-Ari, E.T. & Garrison, J.C. (1986) Localization of preangiotensinogen messenger RNA sequences in the rat brain. Hypertension, 8, 540-543.
22. Machado, R.D., Santos, R.A. & Andrade, S.P. (2000) Opposing actions of angiotensins on angiogenesis. Life Sci., 66, 67-76.
23. Mustafa, T., Hyung, Lee, J., Yeen, Chai, S., Albiston, A.L., McDowall, S.G. & Mendelsohn, F.A.O. (2001) Bioactive angiotensin peptides: focus on angiotensin IV. J. Renin Angiotensin Aldosterone Syst., 2, 205-210.
24. Nickenig, G., Geisen, G., Vetter, H. & Sachinidis, A. (1997) Characterization of angiotensin receptors on human skin fibroblasts. J. Mol. Med., 75, 217-222.
25. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotactic Coordinates, 2nd edn. American Press Inc, San Diego.
26. Porsti, I., Bara, A.T., Busse, R. & Hecker, M. (1994) Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br. J. Pharmacol., 111, 652-654.
27. Reaux, A., Iturrioz, X., Vazeux, G., Fournié-Zaluski, M.-C., David, C., Roques, B.P., Corvol, P. & Llorens-Cortes, C. (2000) Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure. Biochem. Soc. Trans., 28, 435-440.
28. Sarre, S., Thorre, K., Smolders, I. & Michotte, Y. (1997) Microbore liquid chromatography analysis of monoamine transmitters. Meth. Mol. Biol., 72, 185-196.
29. 2 receptor populations in murine neuroblastoma N1E-115 cells. J. Neurochem., 62, 2106-2115.
30. Simões-e-Silva, A.C., Bello, A.P., Baracho, N.C., Khosla, M.C. & Santos, R.A. (1998) Diuresis and natriuresis produced by long term administration of a selective angiotensin-(1-7) antagonist in normotensive and hypertensive rats. Regul. Pept., 74, 177-184.
31. Sirett, N.B., Bray, J.J. & Hubbard, J.I. (1981) Localization of immunoreactive angiotensin II in the hippocampus and striatum of rat brain. Brain Res., 217, 405-411.
32. Smolders, I., Sarre, S., Michotte, Y. & Ebinger, G. (1995) The analysis of excitatory, inhibitory and other amino acids in rat brain microdialysates using microbore liquid chromatography. J. Neurosci. Meth., 57, 47-53.
33. Stragier, B., Sarre, S., Vanderheyden, P., Vauquelin, G., Fournié-Zaluski, M.-C., Ebinger, G. & Michotte, Y. (2004) Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat. J. Neurochem., 90, 1251-1257.
34. Strawn, W.B., Ferrario, C.M. & Tallant, E.A. (1999) Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension, 33, 207-211.
35. Tallant, E.A., Diz, D.I. & Ferrario, C.M. (1999) State-of-the-art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension, 34, 950-957.
36. Tallant, E.A., Xiaowei, L., Weiss, R.B., Chappell, M.C. & Ferrario, C.M. (1997) Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension, 29, 388-393.
37. Thermos, K., Radke, J., Kastellakis, A., Anagnostakis, Y. & Spyraki, C. (1996) Dopamine-somatostatin interactions in the rat striatum: an in vivo microdialysis study. Synapse, 22, 209-216.
38. Trabace, L. & Kendrick, K.M. (2000) Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. J. Neurochem., 75, 1664-1674.
39. Van Heuven-Nolsen, D. & Versteeg, D.H.G. (1985) Interaction of vasopressin with the nigro-striatal dopamine system: site and mechanism of action. Brain Res., 337, 269-276.
40. Wright, J.W. & Harding, J.W. (1997) Important role for angiotensin III and IV in the brain renin-angiotensin system. Brain Res. Rev., 25, 96-124.
41. Zini, S., Fournié-Zaluski, M.C., Chauvel, E., Roques, B.P., Corvol, P. & Llorens-Cortes, C. (1996) Identification of metabolic pathways of brain angiotensin II and III using aminopeptidase inhibitors: Predominant role of angiotensin III in the control of vasopressin release. Proc. Natl. Acad. Sci. USA, 93, 11968-11973.